STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
Abivax's ulcerative colitis data, Fulcrum's scrapped sickle cell drug, and more biotech news from The Readout
Tag
Biotechnology
Live stream
RIVO news Listen to this section's headlines in an AI voice
Now:
Press play to start the stream
This browser does not support voice playback. Try Chrome, Edge or Safari.
The future of agriculture
It's a mild early spring morning at the historic Cottonwood Field Station in western South Dakota, and a herd of 150 Angus steers are scheduled to move to a new…
Biotechnology
RNA ‘cut-and-patch’ tool repairs faulty messages without altering DNA
A research team from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has achieved a significant advance in biotechnology that could…
Biotechnology
Living brain gene activity revealed noninvasively through programmable blood test
Cell function is determined by how DNA is expressed into proteins. That process includes two main steps—transcription, when messenger RNA (mRNA) makes copies of active genes; and translation, when mRNA…
Biotech
STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns
Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but shares of the company tanked on safety concerns.
Biotechnology
Scientists develop virtual tomato training arena for agricultural robots
Researchers at Osaka Metropolitan University have developed a method for creating realistic virtual tomato farms that automatically generate data for training agricultural AI systems. Their approach offers a way to…
Biotech
STAT+: A turning point for pancreatic cancer patients
Eli Lilly announces two China deals, Akeso's lung cancer bispecific payoff, and more biotech news from The Readout
Biotechnology
Biopolymer-based hydrogel formulations for improved seed coating performance
As climate change, soil degradation, and water scarcity place growing pressure on agriculture, scientists are looking for new ways to help crops germinate and grow more efficiently while reducing environmental…
Biotechnology
Pocket-sized device rivals bulky lab machinery in disease and environmental testing
In a major advancement for decentralized health care and environmental monitoring, researchers at Kumamoto University have successfully developed a palm-sized, battery-powered spectrophotometer that matches the performance of massive commercial laboratory…
Biotech
STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds
By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results were encouraging.
Biotech
STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug
Much-awaited results at ASCO show that scientists have indeed found a way to drug a "greasy ball" involved in pancreatic cancer.
Biotechnology
Researchers teach brain cells to play ‘Doom’
Australian researchers have trained lab-grown brain cells on a silicon computer chip to play the nineties shooter game "Doom" and say they are just scratching the surface of what the…
Biotech
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American Society of Clinical Oncology annual meeting. Sign up for email editions here. We’re ASCOmaxxing. Rest…
Biotechnology
Freeze-dried reagents and hand-powered hardware bring biomanufacturing to remote labs
Researchers at the University of Toronto's Leslie Dan Faculty of Pharmacy, working with collaborators around the world, have demonstrated the effectiveness of a suite of low-cost, portable biotechnology tools designed…
Biotech
STAT+: Allogene CEO David Chang stepping down
Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news from The Readout
Pharmalot
STAT+: Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Health
STAT+: The woman behind the world’s biggest longevity competition
Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.
Biotechnology
Nitrogen-fixing genes moved into new bacterial strains, opening path beyond fertilizer
Most major crops, such as wheat and corn, require expensive nitrogen fertilizer to flourish. But what if bacteria could help those plants draw nitrogen from the atmosphere, as peas and…
Biotechnology
Genetically engineering cyanobacteria for the production of sulfated polysaccharide
Biomolecules are naturally occurring molecules that form the basis of living systems. They are widely used in the production of a diverse range of materials. One such widely used biomolecule…
Biotechnology
Improved embryo freezing technique could preserve endangered species
The current practice of freezing embryos—used to assist reproduction in humans or animals or to conserve endangered species—routinely causes ice to form within the cells, ripping through cell membranes, changing…
The Readout LOUD
Biotech exec Jeremy Levin on the industry’s strategic turning point
This week on "The Readout LOUD," longtime biotech exec Jeremy Levin talks about his new book and the industry's strategic turning point. Listen now.
Biotechnology
Electrical pulses reverse aging in sea squirts, offering clues for extending human longevity
A tiny sea creature might hold the secret to reversing the aging process. When treated with a brief series of electrical pulses, sea squirts experience dramatic and long-lasting health improvements…
Biotech
STAT+: Ahead of ASCO, all eyes on pancreatic cancer
Strong results from GSK's hepatitis B drug, engineered heart patches, and more biotech news from The Readout
Adam's Biotech Scorecard
STAT+: An ASCO preview: What to watch for at cancer research’s big meeting
Here's what to watch for at ASCO, cancer research's big meeting, in Chicago.
Biotechnology
DNA ‘nicks’ make for safer, more precise genetic analysis
Researchers at Cornell University have developed a safer and more precise way to study how genes function in living tissues by refining a recently developed CRISPR-based genetic technique in fruit…
Biotechnology
Advancing detection of genome-edited crops in food mixtures
Researchers from Sciensano, partner of the DARWIN project, have published a new paper in npj Science of Food addressing one of the key scientific and regulatory challenges linked to genome-edited…
Biotech
STAT+: Kailera’s own ‘triple-G’ drug also looks very powerful
The business of living forever, Chan Zuckerberg Biohub's AI protein model, and other biotech news from The Readout
Biotechnology
Microcrystals in bioluminescent fish scatter light like a prism
Approximately 75% of marine organisms are bioluminescent, with specialized light-emitting organs called photophores. They use the light they produce for various purposes, like attracting mates, luring prey, or confusing predators.
Biotech
STAT+: Five biotech news updates to stay on top of today
Eli Lilly spends more of its GLP-1 cash, Humira's masterclass in monopoly, and more updates from The Readout
Biotech
STAT+: An AI biotech CEO sets the record straight on AI drug development hype
CEO of BigHat Biosciences, which designs antibody therapies using machine-learning, on how AI can, and cannot, help in drug development.
A STAT Examination
STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA
WASHINGTON — People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney as the FDA’s top food official in 2025. They…
Biotech
STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.
Biotechnology
De‑extinction company says it’s made an artificial egg—if true, it could help save living species
Today's announcement by Texas-based de-extinction company Colossal Biosciences about a successful hatching of chicks from an artificial egg would represent a major innovation, if the claims can be verified.
Biotech
STAT+: Longevity startup Retro Biosciences says latest fundraising values it at $1.8 billion
Retro Biosciences, the longevity startup backed by OpenAI CEO Sam Altman, has raised more money at a $1.8 billion valuation, it announced Friday.
Pharmalot
STAT+: Genentech is soliciting research that can be used to blunt pharma reforms in Washington
How a pharma company is soliciting research that can be used to blunt pharma proposed reforms in Washington.
Biotech
STAT+: Closely watched experimental Parkinson’s drug fails key clinical trial
Biogen and Denali Therapeutics said a closely watched experimental therapy for Parkinson’s disease failed to slow the degenerative brain disorder in a randomized trial.